Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ELCC 2019
The 9th European Lung Cancer Conference
Geneva, Switzerland - 10 Apr - 13 Apr 2019
Presentation Date(s):- 10 Apr - 13 Apr 2019
- Total Presentations: 489
-
+
Opening and welcome
- Type: Opening and welcome
- Presentations: 4
- Coordinates: 4/10/2019, 13:30 - 13:45, Room B
-
+
Welcome to the Congress
13:30 - 13:35 | Presenter: Pilar Garrido Lopez
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Mini Oral session I
- Type: Mini Oral session
- Presentations: 8
- Coordinates: 4/11/2019, 08:00 - 08:50, Room A
-
+
113O - Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001
08:10 - 08:15 | Presenter: Luis Paz-Ares
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Proffered Paper session II
- Type: Proffered Paper session
- Presentations: 8
- Coordinates: 4/11/2019, 09:00 - 10:30, Room A
-
+
Invited Discussant 21O and 108O
09:24 - 09:39 | Presenter: Jürgen Wolf
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
109O - Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2
09:39 - 09:51 | Presenter: Fabrice Barlesi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Lunch & Poster Display session
- Type: Poster Display session
- Presentations: 170
- Coordinates: 4/11/2019, 12:30 - 13:00, Hall 1
-
+
132P - New insights into acquired resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor therapy in lung cancer
12:30 - 12:30 | Presenter: Jana Fassunke
- Abstract
Loading... -
+
134P - Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors
12:30 - 12:30 | Presenter: Svenja Wagener
- Abstract
Loading... -
+
147P - Impact on KRAS-subtypes and TP53 mutations on the prognostic value of KRAS/KEAP1 comutations in non-small cell lung cancer (NSCLC)
12:30 - 12:30 | Presenter: Matthias Scheffler
- Abstract
Loading... -
+
178P - Feasibility of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET for treatment monitoring of brain metastases in lung cancer patients
12:30 - 12:30 | Presenter: Diana SY Abdulla
- Abstract
Loading... -
+
184TiP - FIND: A phase II study to evaluate the efficacy of erdafitinib in FGFR-altered squamous NSCLC
12:30 - 12:30 | Presenter: Lucia Nogova
- Abstract
Loading...
-
+
Implementation of personalised lung cancer care in clinical routine
- Type: Special Symposium
- Presentations: 6
- Coordinates: 4/12/2019, 10:30 - 12:00, Room A
-
+
Experiences from the German Network Genomic Medicine
10:30 - 10:50 | Presenter: Jürgen Wolf
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
